Cannabis plants produce cannabinoids, or chemicals that can induce an effect on the body. When cannabinoids are produced by a plant they are called phytocannabinoids. Humans produce their own cannabinoids, called endogenous cannabinoids. Laboratory or synthetically produced cannabinoids are called synthetic cannabinoids.
The human body has a very intricate endocannabinoid (endogenous cannabinoid) system, with receptors throughout our brain, organs, glands, and immune system. Hence a wide variety of physiological responses, occur when these receptors are stimulated by cannabinoids. These include responses to sleep, memory, appetite, pain, immune response, mood, and cell damage repair and death, Research is currently investigating what endogenous chemicals the human body produces, but the majority of medical discussions surrounding cannabinoids includes the phytocannabinoids.
Cannabis plants produce many phytocannabinoids, but the most well known and studied include CBD (cannabidiol) and THC (Tetrahydrocannabinol). The latter is psychoactive, meaning it can give the user a feeling of euphoria. The former, CBD, in non-psychoactive and researched more than others for its medicinal benefits.
Now plants, just like animals, are classified from Kingdom (Plantae) down to Genus and species. Cannabis comes in a variety of species, including the major ones: C. sativa, C. indica and C. ruderalis.
C. ruderalis is less popular as it has a lower THC content. However it has “autoflowering” qualities, making them useful to cultivators, and if bred with C. sativa or C. indica could enhance the new hybrid in its reproduction.
C. sativa has a higher THC/CBD ratio, hence can provide more euphoria. It reportedly helps decrease anxiety, treat depression and increase appetite. It’s been touted to increase energy and boost creativity. It's also used to help manage attention deficit disorder. Although not approved yet in the US, an oral spray, nabiximol, has been developed and sold in multiple countries to treat neuropathic cancer pain. Its brand name is sold, by prescription, as Sativex® .
C. indica has a higher CBD content and has been used for its sedative properties. It's also used to help anxiety and induce appetite, but will additionally be used to treat pain and muscle spasms.
Epidiolex has received FDA approval to treat some seizures. Its high CBD component is credited for its anti-seizure activity.
There are multiple other strains, each touted to have their own unique properties. 420medbook.com provides the below table.
The challenge, however, is the lack of medical research in each of the different strains. And when a study does come out discussing the medical advantages or disadvantages to using cannabis medicinally, the specific strain may not be mentioned or easily found in the report.
I believe that various strains do have unique properties and there is an art to the field of medical marijuana but more research needs to be done and quickly to avoid random use of cannabis products for treatment of medical conditions.
If you’re a cannabis user living in one of the 42 states where cannabis is still illegal without a prescription, you’re probably planning to march down to your capitol building and lobby your representatives to end cannabis prohibition on April 20. To effectively lobby your representatives requires more than just the commitment to get off the couch one day a year to sit down with your representatives, or more likely, representatives of your representatives, and requesting they support legislation to legalize cannabis in your state.
I was lucky enough to win a scholarship from Students for Sensible Drug Policy (SSDP) to lobby my representatives in Washington D.C. in June of 2013 to legalize cannabis federally. It was a most rewarding experience, and I picked up a few things at a lobbying training seminar led by then executive director of SSDP, Aaron Houston. So here’s the cannabis user’s guide to lobbying on 4/20.
You have to understand that your representative isn’t going to appreciate you wasting his or her time or the time of his or her staff with your drug-induced ramblings. Even if you are a capable orator under the influence, just the appearance or odor of being stoned can undo all your good work and that of your sober comrades.
Getting arrested for smoking a joint at your capitol doesn’t look good, either, so if you must smoke, stay at home on 4/20, where you can still submit a comment to the Food and Drug Administration to remove cannabis from the list of Schedule I drugs. The FDA is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of five drug substances: the cannabis plant and resin, extracts and tinctures of cannabis, delta-9-tetrahydrocannabinol, stereoisomers of tetrahydrocannabinol and Cannabidiol. Comments are due by April 23.
If you wish to be treated as an equal by your representatives or their representatives, dressing as they do is a good place to start. You can’t expect your representatives to thoughtfully consider your recommendations if you’re wearing sweatpants and tennis shoes and look like you just rolled out of bed.
The dress code for members of state congress is business professional, which is exactly what you should be wearing while working in their arena. That’s either a suit or a collared shirt, slacks, a tie and dress shoes for men, and a business suit or an appropriate blouse and skirt or dress for women. “Appropriate,” in this case, refers to an appropriate amount of naked skin displayed, which should never be used as a means to your end. You want your representative to respect you, not covet you.
You’re not just selling your stance; you’re selling yourself. There’s hardly an instance you’re not selling yourself, but in this case, it’s especially important to approach the lobbying of your representatives as you would a job interview. Your interviewers should want to have you back when you leave.
Your representatives can’t dislike you and like your stance. They have to like you before they will even consider your stance. The old saying “you’ll catch more flies with honey than vinegar” is never more true than when lobbying your representatives. Turn up the charm to 11. Smile, and if you can make your representative laugh, you’ll be well on your way to achieving your first goal in lobbying your representatives: being liked.
It might not seem like it at times, but politicians are people, too. They have family and friends they love just like you, and appealing to their feelings will force them to empathize with you. Tell them a personal story of why you use cannabis and how it has helped you. Make yourself the hero of your story and make it easily relatable.
For example: “I suffer from degenerative disc disease that causes chronic lower back pain. Upon being diagnosed at 23 years old, I was immediately prescribed opioids to manage the pain. The plan was to manage the pain until it became surgical, which is when the pain travels down the back of a leg and past the knee. It took a year for my pain to become surgical, and had I not applied for and received a medical marijuana prescription in Montana during that time, I’d either be addicted to opioids or dead.
Once I received my medical marijuana prescription I had no need for the opioids, the dosage of which had increased almost every time I needed a refill. Cannabis is a safer and healthier means of managing chronic pain than opioids, and research has shown that medical marijuana laws may reduce deaths from opioid overdoses.
But people are struggling with ailments and diseases for which medical marijuana prescriptions aren’t allowed, too. I am also an alcoholic, and I’ve been alcohol-free since October 4, 2017. But I couldn’t imagine kicking alcohol without cannabis, and I and thousands of other alcoholics don’t qualify for medical marijuana prescriptions to treat our disease. Instead, we’re called criminals for treating our disease in a safe and healthy manner. So cannabis, a drug that’s never killed a single soul, remains illegal while more than 1,000 Minnesotans die annually from alcohol.”
A cannabis prohibitionist needs a reason to change their mind on cannabis legalization. If they find out their alcoholic family member could quit drinking with the help of cannabis, they’d be more likely to adopt your stance than if you were to feed them a bunch of statistics about fewer fewer deaths in states where medical marijuana is legal.
Your representatives are overwhelmed with legislation spanning a multitude of topics, so it’s unlikely they have a firm grasp on a specific topic unless it’s one of their campaign talking points. Given the reluctance of just about every politician to openly discuss cannabis, in almost every instance, you will know more about cannabis and the effects of cannabis prohibition than your representatives.
You are not lobbying your representatives because of your good looks. You’re lobbying your representatives because you know something they don’t that will help inform their eventual decisions on the matter. Deliver your message knowing you are an authority on the subject, and the confidence you exude will go a long way in persuading your representatives.
If you like this, you might like these Genesis Communications Network talk shows: America’s Healthcare Advocate, The Bright Side, The Dr. Daliah Show, Dr. Asa On Call, Dr. Coldwell Opinion Radio, Drew Pearson Live, Good Day Health, Health Hunters, Herb Talk, Cannabis A to Z
With agents of United States Immigration and Customs Enforcement raiding 7-Elevens across the country intent on deporting illegal immigrants and punishing the companies that employ them, immigration reform is taking center stage this week in Washington, D.C.
Democrats have long hoped to provide a path to citizenship for immigrants temporarily allowed in the country under the Deferred Action for Childhood Arrivals policy, which allows children brought to America by family members illegally to remain in the country temporarily and acquire work visas. As of this writing, a federal injunction has blocked the Trump Administration from rescinding the work permits of these undocumented immigrants. But that's not a permanent solution.
A bipartisan group of Senators has come to an agreement on an immigration deal, but Donald Trump has not offered his support of the bill. The bill reportedly includes a path for DACA recipients to become citizens and changes to the State Department's diversity visa lottery program and family-based immigration policies while also providing a border security funding package.
Whatever the bipartisan deal looks like now, it’s going change drastically as negotiations take place to please the President become passable in the Senate and the House of Representatives. So what can we expect from the immigration negotiations?
Trump was asked if he would support a DACA bill that did not include money for the border wall he has proposed in a news conference, Wednesday at the White House. “No, no, no,” was his answer.
Trump won’t approve immigration legislation if it doesn’t approve funding for a border wall. It was his biggest campaign promise -- and that Mexico would pay for it. Mexico isn’t paying for it, and Senate Democrats won’t likely allow tax dollars to be spent on a border wall. But there’s still Ted Cruz’s bill to make El Chapo (Joaquín El Chapo Guzmán Loera) and profits secured from other drug lords to pay for the wall.
The Department of Homeland Security estimated in February 2017 that Trump’s border wall would cost roughly $21.6 billion. U.S. authorities are seeking the forfeiture of roughly $14 billion in profits from illicit drug trafficking by El Chapo.
U.S. attorney general Jeff Sessions gave Republicans leverage in negotiations by ending protections for states with legal marijuana, so Republicans could very well demand funding for a border wall in exchange for protections of medical and recreational marijuana providers and users.
That doesn’t mean Trump will be able to fund his border wall exclusively with taxpayer dollars, though. Congressional Democrats are already frustrated by a tax plan that the nonpartisan Congressional Budget Office says will add $1.4 trillion to the federal deficit over the next decade. Even if Trump’s tax plan will raise America’s gross-domestic product by .5 percent annually, it still increases the federal deficit by $1.252 trillion. And now Congressional Republicans have their sights set on cutting Medicare, Medicaid and Social Security benefits.
Congressional Democrats will have to find some solace in fulfilling the dreams of Dreamers currently residing in America under DACA, because immigrants residing in the country under the State Department's diversity visa lottery program and family-based immigration policies will be deported en masse.
The ICE raids of 7-Elevens throughout the country are just the beginning. Refugees residing in America with Temporary Protected Status will likely have their statuses terminated and be forced to return to their home countries, which aren’t likely ready to receive them. Most of these refugees escaped natural disasters or war. It was announced Monday that nearly 200,000 TPS migrants from El Salvador must leave the country, and there are another 125,000 TPS migrants residing in American who could be next.
To give you a sense of who these TPS migrants are, 81 to 88 percent of them are employed, which is a considerably higher rate than the 63 percent of American-born citizens who are employed. They do work many Americans wouldn’t do if the jobs were available to them -- 51,700 work construction, 32,400 in food service, 15,800 are landscapers, 10,000 more take care of your kids in daycares and 9,200 work in grocery stores. Almost a third of all TPS migrants are paying mortgages, too.
Trump will chalk these deportations up as jobs created for Americans, but it won’t necessarily result in a strengthened U.S. economy. The Center for American Progress estimates "a policy of mass deportation would immediately reduce the nation's GDP by 1.4 percent, and ultimately by 2.6 percent, and reduce cumulative GDP over 10 years by $4.7 trillion."
Agriculture and construction industries are expected to be the industries hardest hit by mass deportations, so housing shortages will worsen as will agriculture exports due to a lack of a sufficient labor force. Americans aren’t suddenly going to flock to farms and ranches in search of jobs vacated by immigrants.
It’s also estimated that illegal immigrants and their employers pay between $7 and $12 billion into Social Security, which would further devastate the program if Congressional Republicans indeed cut funding for it.
So what we can expect from the immigration reform negotiations is: 1) some sort of border wall being built on the U.S.-Mexico border, 2) possible marijuana protections for states with legal and medical marijuana legislation in effect, 3) more deportations, and 4) a worse U.S. economy.
If you like this, you might like these Genesis Communications Network talk shows: The Costa Report, Drop Your Energy Bill, Free Talk Live, Flow of Wisdom, America’s First News, America Tonight, Bill Martinez Live, Korelin Economics Report, The KrisAnne Hall Show, Radio Night Live, The Real Side, World Crisis Radio, The Tech Night Owl, The Dr. Katherine Albrecht Show, Free Talk Live
While United States Attorney General Jeff Sessions rescinded Obama-era, federal protections for recreational marijuana businesses and users in states that have adopted legal cannabis legislation, that won’t affect states’ medical marijuana providers and users -- at least until Jan. 19.
Indications are that medical marijuana will be off the table when it comes to the Justice Department’s crackdown on cannabis. President Donald Trump went on the record in support of medical marijuana prior to the election, so it’s unlikely Sessions would act in a manner that could jeopardize his President’s reelection chances any further. But if Congress can’t come to an agreement to fund the government before Jan. 19, the Rohrabacher–Farr amendment prohibiting the Justice Department from spending federal funds to interfere with states’ implementation and enforcement of medical cannabis laws will expire.
The Rohrabacher-Farr amendment must be renewed each fiscal year to remain in effect, and is usually done so through omnibus spending bills. It was most recently renewed in a stopgap spending bill on Dec. 22, which expires Jan. 19. So if Congress fails to pass a budget for the fiscal year or at least another stopgap spending bill to fund the government temporarily, medical marijuana providers and patients will no longer be protected by Rohrabacher-Farr and subject to federal prosecution.
Sessions is making sure the Justice Department is prepared for the opportunity to enforce federal cannabis law. He appointed 17 interim U.S. attorneys general just days prior to rescinding the protections for recreational cannabis providers and users. The 17 temporary appointees can serve for 120 days before Trump must nominate permanent U.S. attorneys and seek to have them confirmed by the Senate. Sessions has empowered all 94 U.S. attorneys to enforce cannabis law as they see fit.
Republican Senator Cory Gardner of Colorado said he would block Trump's Justice Department judicial nominees until the decision is reversed. Democratic Senator Ron Wyden of Oregon, a state where cannabis is legal to use by adults, insists that protecting states with legal cannabis legislation should be part of budget negotiations to avoid a government shutdown. If the government shuts down, the Drug Enforcement Agency (DEA) would continue to be funded, so raids of both recreational and medical marijuana providers would be a possibility. Even if Sessions doesn’t crackdown on cannabis, he’s given Republicans some leverage in negotiating a new budget to fund the government. Perhaps in exchange for continued protection for medical and recreational marijuana states, Trump will get his border wall funded.
Regardless, medical and recreational marijuana providers and users haven’t been this vulnerable since before Rohrabacher-Farr went into effect in December of 2014. If the bipartisan condemnation of Sessions’ decision is any indication of what’s to come, protecting cannabis markets, both medical and recreational, will be a top priority over the next week.
As of January 2017, recreational cannabis markets had created 123,000 full-time jobs in America, and a recent report by New Frontier Data forecasts that tax revenues from legal marijuana sales were $559 million in 2017.
If you like this, you might like these Genesis Communications Network talk shows: America’s Healthcare Advocate, The Bright Side, The Dr. Daliah Show, Dr. Asa On Call, Dr. Coldwell Opinion Radio, Drew Pearson Live, Good Day Health, Health Hunters, Herb Talk, Free Talk Live
The deepest of Republican values is to respect states’ rights, but attorney general Jeff Sessions isn’t doing so by asking Congress to let him prosecute medical marijuana dispensaries.
Sessions wrote a letter to Congress in May requesting protections of state marijuana laws that have been in effect since 2014 be undone so he can fill America’s already-full jails and prisons, both rural and urban, with non-violent, drug offenders. The Rohrabacher-Farr amendment doesn’t allow the Justice Department to spend federal dollars preventing states from enforcing their own marijuana laws. If that’s no longer the case, medical marijuana providers can expect Drug Enforcement Agency (DEA) raids.
It’s no surprise to anyone familiar with Sessions that he’d want to lock up potheads. He’s long despised marijuana and went so far as to cite the opioid epidemic as a reason to enforce federal marijuana prohibition, because he’s either un- or misinformed, or just doesn’t care about the facts.
In states where medical marijuana is legal, either medically or recreationally, opioid overdose deaths are down considerably. States with medical cannabis laws had a 24.8 percent lower annual opioid overdose mortality rates compared with states without medical cannabis laws, a 2014 study revealed.
Sessions would be better served focusing his efforts on legalizing medical marijuana federally by rescheduling cannabis so it could be prescribed by doctors throughout America. Emergency department visits involving misuse or abuse of prescription opioids increased 153 percent between 2004 and 2011. So obviously the easiest way to slow this increase is to offer a prescription pain reliever that has never killed a soul and is already linked with fewer opioid overdoses.
These sort of Republicans like Sessions are the worst sort because they’re not even Republicans. They’re fascists. Only fascists would have an interest in governing what people do in the privacy of their own homes, including the bedroom.
If you think tax dollars should be spent to take a proven medicine away from people with debilitating pain or illness, you’re no Republican. And no Republican would advocate for bigger government, which is exactly what you’ll get if the Justice Department is allowed to spend your taxes busting medical marijuana providers.
Medical marijuana is supported by 94 percent of Americans according to this Quinnipiac poll. It has bipartisan support in Congress as well, so hopefully your representatives don’t cave to Sessions request. Contact your Senators and Representatives to express your opinion on the matter.
If you like this, you might like these Genesis Communications Network talk shows: America’s Healthcare Advocate, The Bright Side, The Dr. Daliah Show, Dr. Asa On Call, Dr. Coldwell Opinion Radio, Drew Pearson Live, Good Day Health, Health Hunters, Herb Talk, Free Talk Live
For centuries, multiple civilizations have used cannabis to treat various medical conditions, including seizures. This week researchers from NYU Langone’s Comprehensive Epilepsy Center found a chemical in marijuana to do just that.
A study published in the New England Journal of Medicine found that a liquid medication containing cannabidiol, one of the many chemicals in marijuana, reduced convulsive seizures in children by half.
Created by GW Pharmaceuticals, Epidiolex, brand name, was the drug used in this study and has not yet received FDA approval.
As opposed to THC, tetrahydrocannabinol, the psychoactive ingredient in marijuana, cannabidiol does not cause euphoria and has been the subject of many studies for its medicinal applications.
In this study, researchers tested 120 children with Dravet’s syndrome and found those given Epidiolex not only suffered less seizures, but 5% of the children were seizure-free during the 14 week trial.
Side effects, however, were reported such as fatigue, vomiting, diarrhea and anorexia (loss of appetite).
A seizure occurs when there is abnormal electrical activity in the brain. If the electricity doesn’t conduct properly, brain function gets disrupted. This could lead to convulsions (involuntary jerking movements), loss of muscle tone, changes in senses such as vision, hearing and smell, loss of bladder control, loss of consciousness and sometimes stroke, brain damage and death.
Epilepsy is a neurological disorder in which a person has recurrent, unprovoked seizures.
Dravet Syndrome is a rare genetic condition that starts in infancy. Children can suffer a variety of seizures and may eventually suffer from developmental delay and learning disorders. What makes Dravet Syndrome so severe is the fact that the seizures are refractory to many anti-seizure medications.
More research needs to be done in this area, but these preliminary findings give parents and the medical community hope that a pharmaceutical option could exist in the near future for these devastating and potentially fatal seizures.
Multiple states in the US currently allow recreational marijuana or medicinal use of cannabis and multiple more states may be following suit in upcoming elections.
Even those who support the legalization have concerns over driver safety and how to determine if one is impaired.
Breathalyzers are currently being developed and tested but are not ready for roadway spot checks. Moreover, breathalyzers may have difficulty accurately detecting both inhaled and ingested marijuana.
California law enforcement officers are piloting road-side saliva tests but objective data is still lacking regarding the accuracy of oral fluid tests.
Currently when law enforcement tests an impaired driver for marijuana use, a urine test can be performed which only looks for a metabolite called THC-COOH. Despite its abbreviation it is a non-psychoactive component of marijuana, as opposed to delta-9-tetrahydrocannabinol (delta-9-THC), which does cause euphoria. Hence the shortcoming to this testing method are twofold, as the non active THC-COOH isn’t even the correct metabolite to measure intoxication and it can linger in the body for weeks, hence not allowing an adequate quantitative measure to determining one’s impairment.
Two medical students, however, figured out what needs to be tested and how. Graham Lambert and Charles Cullison, both entering their third year at Touro University Nevada, performed research for an American College of Legal Medicine (ACLM) poster contest.
One of the lead researchers and osteopathic medical student Graham Lambert said, “This is an issue because it’s non-psychoactive. It stays in the body for long periods of time, long after any psychoactive effects.” Their research lead them to conclude that testing should instead look for an alternate THC metabolite, 11-OH-THC.
Why? Let’s break this down. Now both delta-9-THC and 11-OH-THC are psychoactive compounds that can be tested in the blood. However law enforcement has to determine whether euphoria was present and a factor in one’s unlawful driving. Both delta-9-THC and 11-OH-THC crosses the blood brain barrier, a semi-permeable endothelial cell barrier that helps decide what substances can enter and leave the brain. But 11-OH-THC’s is more readily active and can bind to the brain’s cannabinoid receptors tighter, lasting longer and causing more of a psychoactive effect.
Additionally, 11-OH-THC is a metabolite also seen in high quantities after ingesting marijuana edibles.
IMAGE FROM SAPAINSOUP.COM
In 2012, Sharma et al found the 11-OH-THC to last twice as long in the blood than delta-9-THC, which would make sense due its strong binding properties. Yet the psychoactive 11-OH-THC will rapidly be metabolized to an inactive form hence its presence on a test will signify activity rather than just “hanging around”.
Once Lambert and Cullison determined this, they went to Assemblyman Steve Yeager, D-Las Vegas, who is Chair of the Assembly Judiciary Committee. Yeager helped sponsor a bill, AB135 that would convert marijuana testing for drivers from the inaccurate urine test to a blood test that would look for specifically 11-OH-THC.
Also lead researcher and osteopathic medical student, Charles Cullison said, “Blood alone accurately shows the levels of hydroxy (11-OH-THC) and marijuana.”
In regards to getting the bipartisan law passed through the State Senate with a “Veto-less” majority, Cullison stated, “We couldn’t have done this without the help of many people.”
After Nevada lawmakers passed AB 135, Governor Brian Sandoval signed it into law. The antiquated urine testing will not be used to test drivers pulled over for possible DUI but a blood test instead.
The legal limit of marijuana that is measured in nanograms per milliliter ng/ml would be 2 ng/ml for delta-9-THC and 5 ng/ml for 11 Hydroxy-THC. This does not change with passage of AB135, nor do the circumstances surrounding when to test, as current protocols are in place once a person fails his sobriety test.
In 2015 Dr. Thad Ocampo and Dr. Tonya Rans published a paper looking at cannabis allergies that ranged from eczema to asthma to anaphylaxis.
Daily Mail now reports 36 million Americans could be allergic to marijuana, stating 73 percent of the 50 million people who react to pollen also have issues with cannabis – and the figure is rising. This comes as no surprise as marijuana is a plant that carries pollen. Those exposed to second hand cannabis may be at risk as well. In 1971, a 29 year old woman claimed to have smoked marijuana for the first time when she went into a full anaphylactic reaction, being unable to breath.
Cannabis sativa is one of the more common strains of cannabis used and its hypersensitivity could cause one to have any of the following:
Runny eyes, conjunctivitis
Image from Positive Vibrations
Cannabis indicia is the other more common strain, whose leaves are wider and may pose allergic risks as well. Dr. Ocampo and Rans also discusses cannabis seed encrusted seafood which caused an anaphylactic reaction in a patient who was not allergic to seafood.
EpiPens could provide support for those suffering reactions and may need to be on hand for those who smoke or are exposed to marijuana smoke.
Allergic reactions occur when an allergen enters the body and the immune system tries to reject it. This defense mechanism, however, could cause many symptoms, including bronchoconstriction, preventing one from being able to breathe. EpiPens provide epinephrine opening up the bronchioles and therefore allowing air exchange.
LearnHealthSpanish.com / Medical Spanish made easy.
Daliah Wachs, MD, FAAFP is a Board Certified Family Physician. The Dr. Daliah Show , is nationally syndicated M-F from 11:00 am - 2:00 pm and Saturday from Noon-1:00 pm (all central times) at GCN.
In a study published in the journal Nature Medicine, researchers from Hebrew University and the University of Bonn discovered that daily marijuana use could help prevent the “slowdown” that occurs in our brains as we age.
THC, tetrahydrocannabinol, the main psychoactive ingredient in cannabis, was found to boost memory and learning, cognitive function, in older mice.
In the study, researchers gave THC daily to groups of mice who were 2 months old, one year old and 18 months old. Then the mice solved a water maze. The older mice who were not given the THC had difficulty recognizing familiar objects and navigating the maze. But those who were given THC scored similarly to younger vibrant mice, and did so for a month after the dosing stopped.
Now the younger mice given the THC appeared to score poorly compared to younger mice not given the THC. The study authors believe the THC is stimulating the brain’s endocannabinoid system, which is a biochemical pathway that slows down with aging.
It’s a system within the brain and spinal cord and peripheral nervous system with receptors that help regulate a variety of actions including memory, mood, appetite, and pain. The body makes its own “cannabinoids” which work at the synapse where neurotransmitters are released. Our own cannabinoids (endogenous cannabinoids, hence endocannabinoids) help regulate what is being neurotransmitted. Exogenous (outside) THC that is inhaled/ingested competes with a body’s own cannabinoids for these receptors causing changes in what signals get released.
This isn’t the first time marijuana has been found to improve brain health.
Previous studies found cannabis to increase brain-derived neurotrophic factor (BDNF) protecting brain cells and stimulating new cell growth. In 2008 a study in mice found THC to improve memory in older rats as well as decrease brain inflammation.
However in 2016 a study published in Nature found cannabinoids to activate CB1 receptors within the mitochondria of hippocampal neurons, which resulted in memory loss. Their study suggested that chronic use of marijuana permanently affected the brain cell’s mitochondria, thereby causing long term memory loss.
So is marijuana good for the brain or not? Studies in mice conflict however, researchers are slowly narrowing down why it helps and why it hurts. Give it more time before placing any bets….
LearnHealthSpanish.com / Medical Spanish made easy.
Daliah Wachs, MD, FAAFP is a Board Certified Family Physician. The Dr. Daliah Show , is nationally syndicated M-F from 11:00am-2:00pm and Saturday from Noon-1:00pm (Central) at GCN.
Americans consume. Whether it’s food, energy, cars, second homes or home furnishings, Americans consume most of the world’s supply. Americans waste 30 to 40 percent of our food supply. America also has an entire city dedicated to sin, so it felt wrong to leave out things Americans obviously don’t need but buy anyway, legal or otherwise. America was built on tobacco after all, and still is a leading producer of tobacco leaves, producing 766.6 million pounds in 2012.
While cigarette use is declining in the United States, e-cigarette use is way up. Disposable e-cigarette sales increased an incredible 320 percent from 2012 to 2013, according to the Centers for Disease Control and Prevention. People who would never consider smoking cigarettes smoke e-cigarettes instead. Smokeless tobacco sales were also up over the same period. Despite smoking-related illness costing the U.S. $300 billion each year, Americans were third in cigarette consumption globally (albeit a distant third to China).
The upside of using an addictive, cancer-causing product, if there is an upside, is If you’re buying cigarettes or smokeless tobacco in America, then you’re supporting an American company. It’s that easy. Virginia’s Altria, formerly known as Philip Morris and parent company of the U.S. Smokeless Tobacco Company, raised $25.43 billion of revenue in 2015. Vector Group, owner of Liggett, headquartered in Durham, N.C., raised $1.6 billion in 2014. Reynolds American, parent company of RJ Reynolds and Santa Fe Natural Tobacco, makers of American Spirit cigarettes, raised $8.236 billion in 2013.
American-made e-cigarettes, however, are harder to find. White Cloud, ProVape and Hana Modz are apparently American, but ProVape has closed. If you’re going to smoke or vape, and I nor GCN Live advises you do, smoke or vape American.
Like Scotland and Scotch whisky, and France and champagne, America has places known for alcohol -- most notably bourbon and Tennessee whiskey. While the two are grouped together for international trade reasons, producers of Tennessee whiskey don’t label their product as bourbon, which is why I drink bourbon. I also drink “sparkling wine,” which is champagne made anywhere but France using the exact same method. I can’t afford Scotch.
Like tobacco, alcohol misuse costs Americans a pretty penny -- $249 billion in 2010 according to the National Institute on Alcohol Abuse and Alcoholism. And Americans are consuming more alcohol than in the past, but aren’t in the top five as far as nations go.
It’s pretty easy to determine whether or not your alcoholic beverage is American-made. Just check the label. Thrillist ranked the top 25 American craft distilleries recently. A few of my favorites -- Jim Beam and Maker’s Mark -- are owned by Japanese company Suntory Holdings, Ltd. I know, it reminds me of Lost in Translation, too, and kind of makes me want to cry, but both are still made in Kentucky, with Maker’s Mark being the oldest operating bourbon distillery in the world.
Beer is the alcoholic beverage of choice amongst Americans, though, accounting for 85 percent of the alcoholic beverage market. If you’re into microbrews, you’re pretty much in luck if you live in America. You’re not only drinking American, but shopping locally. All that money you spend goes right back into your community’s economy. There’s over 3,000 American breweries and over 2,500 American breweries on this map. You can find one near you here.
If you drink Budweiser, Busch or Miller beer, your money goes to Belgium. Anheuser-Busch owns Miller now. If you drink Coors, your money stays in the U.S. and Canada. If you drink Sam Adams, your money goes to Boston. If you drink Old Milwaukee or Pabst Blue Ribbon, your money goes to California.
Speaking of California, the American wine industry is buoyed by California’s Napa Valley, and 90 percent of all American wine comes from the West Coast. Again, figuring out if your wine is American-made is as easy as reading the label. Wineries aren’t shy about it. Constellation Brands, the largest wine company in the world, started in the Finger Lakes region of New York. If you drink Barefoot, your money goes to California. If you drink Franzia, your money goes to California. Keep in mind that trying wines from different places is like tasting the place itself, so don’t let an American bias stop you from trying an Argentinian Malbec or Italian Chianti. That would be a shame.
Only Icelanders smoke more pot per capita than Americans. A Gallup survey in 2016 found that 13 percent of Americans were using marijuana regularly, up from seven percent in 2013. Marijuana has become a $6.7 billion industry in the United States, according to Forbes.
It’s a pretty good bet the weed you’re smoking is American if you’re smoking it within American borders. The closer you get to a border, the worse chance you have of coming across un-American marijuana, but with the public opinion of marijuana changing and legislation legalizing the drug increases, supply and demand also increase. Business Insider was nice enough to put together a list of the 25 best marijuana dispensaries in every state in which it’s legal, either medically or recreationally.
If you’re in Colorado, visit The Farm in Boulder or Doctor’s Orders in Denver. Each place has a great deal every day. If you happen to be taking a tour of wineries in the Columbia Basin of Washington, stop by Green2Go in Prosser.
Americans consume 80 percent of the world’s opiate pain pills. That’s what we call an epidemic, and Donald Trump has put Chris Christie in charge of solving America's’ addiction to pain pills. It’s personal for Christie, too. He lost a longtime friend to an opiate overdose.
That’s right, cocaine can be prescribed by a doctor. America is third in the world when it comes to cocaine consumption and second in consumption of prescribed stimulants like Adderall and Ritalin. The U.S. is fifth in consumption of amphetamine-type stimulants, so a lot of Americans are amped up.
Cocaine is expensive and hard to find in most places, but most people can easily get a prescription for ADHD medication and quickly move up the scale from the extended release capsules (which contain beads that are designed to keep people from crushing and snorting them) to the immediate release pills (which are not).
I actually suffer from adult ADHD and take 15 mg of immediate release Adderall most workdays. It has increased my production immensely. I’ve gone from working with 30 tabs open in my web browser to 10 or less, but before you schedule an appointment, check out this list to see if you actually suffer from ADHD symptoms. And when you take the test given by your doctor, take it honestly. In the words of my best friend, “It’s a tool, not a lifestyle.”
If you’re already using a generic stimulant, which most people do, it’s likely produced by New Jersey’s CorePharma.
America is ranked eighth in consumption of Ecstasy or MDMA. Unless you have a test kit, it’s almost impossible to determine whether your MDMA is pure let alone made in America. If you’re taking Ecstasy you’re likely taking meth as well, so unless you’re one of the people using the drug for PTSD in clinical studies, just steer clear of Ecstasy until it’s legal and regulated (as early as 2021).
So there are the most common vices of Americans. In order to assure your consuming American-made, though, check your labels and do some research into the companies providing the products.
Next up in our Made in America series we’ll look at American-made firearms and compare them to foreign firearms.
If you like this, you might like these Genesis Communications Network talk shows: America’s Healthcare Advocate, The Bright Side, The Dr. Daliah Show, Dr. Asa On Call, Dr. Coldwell Opinion Radio, Good Day Health, Health Hunters, Herb Talk, Free Talk Live